The novel therapy of the medication represents a major development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – providing https://tirzepatide-peptide562336.blog4youth.com/42546299/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment